159 related articles for article (PubMed ID: 15133114)
1. Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes.
Fujinaga Y; Inoue K; Watarai S; Sakaguchi Y; Arimitsu H; Lee JC; Jin Y; Matsumura T; Kabumoto Y; Watanabe T; Ohyama T; Nishikawa A; Oguma K
Microbiology (Reading); 2004 May; 150(Pt 5):1529-1538. PubMed ID: 15133114
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes.
Fujinaga Y; Inoue K; Nomura T; Sasaki J; Marvaud JC; Popoff MR; Kozaki S; Oguma K
FEBS Lett; 2000 Feb; 467(2-3):179-83. PubMed ID: 10675534
[TBL] [Abstract][Full Text] [Related]
3. Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin.
Lee JC; Yokota K; Arimitsu H; Hwang HJ; Sakaguchi Y; Cui J; Takeshi K; Watanabe T; Ohyama T; Oguma K
Microbiology (Reading); 2005 Nov; 151(Pt 11):3739-3747. PubMed ID: 16272395
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin.
Nakamura T; Kotani M; Tonozuka T; Ide A; Oguma K; Nishikawa A
J Mol Biol; 2009 Jan; 385(4):1193-206. PubMed ID: 19071137
[TBL] [Abstract][Full Text] [Related]
5. Molecular properties of each subcomponent in Clostridium botulinum type B haemagglutinin complex.
Arimitsu H; Sakaguchi Y; Lee JC; Ochi S; Tsukamoto K; Yamamoto Y; Ma S; Tsuji T; Oguma K
Microb Pathog; 2008 Aug; 45(2):142-9. PubMed ID: 18550324
[TBL] [Abstract][Full Text] [Related]
6. Characterization of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one subcomponent of haemagglutinin (HA1).
Inoue K; Fujinaga Y; Honke K; Yokota K; Ikeda T; Ohyama T; Takeshi K; Watanabe T; Inoue K; Oguma K
Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2533-2542. PubMed ID: 10517606
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin.
Mahmut N; Inoue K; Fujinaga Y; Hughes L; Arimitsu H; Sakaguchi Y; Ohtsuka A; Murakami T; Yokota K; Oguma K
J Med Microbiol; 2002 Apr; 51(4):286-294. PubMed ID: 11926732
[TBL] [Abstract][Full Text] [Related]
8. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873.
Nakajima H; Inoue K; Ikeda T; Fujinaga Y; Sunagawa H; Takeshi K; Ohyama T; Watanabe T; Inoue K; Oguma K
Microbiol Immunol; 1998; 42(9):599-605. PubMed ID: 9802560
[TBL] [Abstract][Full Text] [Related]
9. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin.
Kouguchi H; Watanabe T; Sagane Y; Ohyama T
Eur J Biochem; 2001 Jul; 268(14):4019-26. PubMed ID: 11453996
[TBL] [Abstract][Full Text] [Related]
10. Role of C-terminal region of HA-33 component of botulinum toxin in hemagglutination.
Sagane Y; Kouguchi H; Watanabe T; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
Biochem Biophys Res Commun; 2001 Nov; 288(3):650-7. PubMed ID: 11676492
[TBL] [Abstract][Full Text] [Related]
11. Crystallization and preliminary X-ray analysis of the HA3 component of Clostridium botulinum type C progenitor toxin.
Nakamura T; Tonozuka T; Kotani M; Obata K; Oguma K; Nishikawa A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Dec; 63(Pt 12):1038-40. PubMed ID: 18084087
[TBL] [Abstract][Full Text] [Related]
12. Sugar-binding sites of the HA1 subcomponent of Clostridium botulinum type C progenitor toxin.
Nakamura T; Tonozuka T; Ide A; Yuzawa T; Oguma K; Nishikawa A
J Mol Biol; 2008 Feb; 376(3):854-67. PubMed ID: 18178224
[TBL] [Abstract][Full Text] [Related]
13. Clostridium botulinum type A haemagglutinin-positive progenitor toxin (HA(+)-PTX) binds to oligosaccharides containing Gal beta1-4GlcNAc through one subcomponent of haemagglutinin (HA1).
Inoue K; Fujinaga Y; Honke K; Arimitsu H; Mahmut N; Sakaguchi Y; Ohyama T; Watanabe T; Inoue K; Oguma K
Microbiology (Reading); 2001 Apr; 147(Pt 4):811-819. PubMed ID: 11283277
[TBL] [Abstract][Full Text] [Related]
14. Characterization of nontoxic-nonhemagglutinin component of the two types of progenitor toxin (M and L) produced by Clostridium botulinum type D CB-16.
Ohyama T; Watanabe T; Fujinaga Y; Inoue K; Sunagawa H; Fujii N; Inoue K; Oguma K
Microbiol Immunol; 1995; 39(7):457-65. PubMed ID: 8569530
[TBL] [Abstract][Full Text] [Related]
15. Hemagglutinin gene shuffling among Clostridium botulinum serotypes C and D yields distinct sugar recognition of the botulinum toxin complex.
Miyata K; Suzuki T; Hayashi S; Miyashita S; Ohyama T; Niwa K; Watanabe T; Sagane Y
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26223883
[TBL] [Abstract][Full Text] [Related]
16. Multivalency effects of hemagglutinin component of type B botulinum neurotoxin complex on epithelial barrier disruption.
Amatsu S; Matsumura T; Yutani M; Fujinaga Y
Microbiol Immunol; 2018 Feb; 62(2):80-89. PubMed ID: 29266585
[TBL] [Abstract][Full Text] [Related]
17. Characterization of sugar recognition by the toxin complex produced by the Clostridium botulinum serotype C variant strain Yoichi.
Matsuo T; Miyata K; Inui K; Ito H; Horiuchi R; Suzuki T; Yoneyama T; Oguma K; Niwa K; Watanabe T; Ohyama T
FEMS Immunol Med Microbiol; 2011 Oct; 63(1):35-43. PubMed ID: 21635567
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex.
Amatsu S; Sugawara Y; Matsumura T; Kitadokoro K; Fujinaga Y
J Biol Chem; 2013 Dec; 288(49):35617-25. PubMed ID: 24165130
[TBL] [Abstract][Full Text] [Related]
19. Clostridium botulinum type C hemagglutinin affects the morphology and viability of cultured mammalian cells via binding to the ganglioside GM3.
Sugawara Y; Iwamori M; Matsumura T; Yutani M; Amatsu S; Fujinaga Y
FEBS J; 2015 Sep; 282(17):3334-47. PubMed ID: 26077172
[TBL] [Abstract][Full Text] [Related]
20. Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization.
Fujinaga Y; Inoue K; Shimazaki S; Tomochika K; Tsuzuki K; Fujii N; Watanabe T; Ohyama T; Takeshi K; Inoue K
Biochem Biophys Res Commun; 1994 Dec; 205(2):1291-8. PubMed ID: 7802661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
